Friday, July 20, 2018
Company News: Page (1) of 1 - 06/29/18 Email this story to a friend. email article Print this page (Article printing at page facebook
Compass Clinical Consulting Announces Lisa Prytula, MA, RN-BC as Associate Managing Director

(June 29, 2018)

Former Director of Standards Interpretation at The Joint Commission Joins Compass Clinical Consulting Leadership Team

CINCINNATI, June 29, 2018 (GLOBE NEWSWIRE) -- Lisa Prytula, MA, RN-BC, formerly the Director of Standards Interpretation at the Joint Commission (TJC) has joined Compass Clinical Consulting’s leadership as Associate Managing Director.

Ms. Prytula brings to Compass expert knowledge in the accreditation standards and Centers for Medicare and Medicaid Services (CMS) Conditions of Participation (CoPs). With this expertise, along with hospital leadership experience, project management skills, and a customer service focus, Lisa is positioned to provide both clinical and operational leadership and support to clients across all of Compass’s service lines.

Lisa has more than 20 years of experience specializing in healthcare quality, accreditation and regulatory compliance, and performance improvement. Through a career dedicated to professional development and education, evidence-based practice and research, and nursing leadership, she embodies a commitment to helping healthcare organizations improve quality and patient safety.

In her time with TJC and the Accreditation Commission for Education in Nursing (ACEN), Lisa worked with nearly 200 organizations to assess compliance with accreditation standards and the CMS CoPs, providing expertise across a range of healthcare settings including large university medical centers, specialty hospitals, long-term acute care hospitals, community hospitals, critical access hospitals, and ambulatory healthcare settings.

Previously, Lisa held positions in nursing leadership and professional development in hospital medical-surgical and oncology departments, where she led interdisciplinary performance improvement initiatives and conducted pain management and transcultural nursing research.

Lisa earned graduate and undergraduate degrees in nursing from Augsburg University in Minneapolis, MN. She is a Registered Nurse, Board Certified by the American Nurse Credentialing Center,  and a TJC Robust Process Improvement Yellow Belt. She has presented at numerous conferences and workshops on topics in support of patient safety, quality of care, and high reliability, including continuous survey readiness, standards compliance, pain management, and transcultural nursing care.

Read Lisa’s latest article, “Preliminary Denial of Accreditation: How to successfully resolve.”

About Compass Clinical Consulting

Compass Clinical Consulting has helped hospitals, health systems, and other healthcare organizations improve performance and overcome obstacles to providing safe, quality patient care since 1979. Compass is clinically focused, driving change through three services lines: clinical and operations performance improvement, accreditation and regulatory compliance, and interim healthcare leadership.

Tel. 800-241-0142
Email: [email protected]

Page: 1

Related Keywords:
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

  • Healthcare IT Market 2018 - 2023 with SWOT Analysis regarding upcoming Changes and Technology Adaptations in Global Healthcare Sector
  • Global Prosthetic Heart Valve Market Reaching at a CAGR of +12.70% by Geography, Deployment Model, Component, and Key players are Boston Scientific Cardiology, CryoLife, Inc., Abbott
  • Trauma Fixation Global Market to Register Steady Expansion During 2018-2025
  • Global Surgical Apparel Market Will Reach USD 2,966.58 million by 2024: Zion Market Research
  • Wireless Health Market To Witness Enhanced Growth Owing To Rising Application of Wireless Health Devices And Growing Patient-Centric Methodology Till 2025 | Million Insights

  • Mesothelioma is a Deadly Cancer and it’s Completely Preventable
  • HedgePath Pharmaceuticals Granted Exclusive Option to License UCONN's Patented Chemical Analogues of Itraconazole
  • Alligator Bioscience Submits Application to Start Clinical Phase I Study in Cancer Patients with ATOR-1015, a Unique CTLA-4 and OX40 Binding Antibody
  • Yisheng Biopharma Announces Opening of New Business Divisions in Cambodia, Expanding Presence within Southeast Asia
  • Omega-3 Market to Reach US$ 16.37 Bn by 2023, Globally -

    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines